EcoDrugPlus

G Protein-Coupled Receptor 84

Ensembl ID : ENSNFUG00015009541
Gene Symbol: GPR84
3 Cross references
124 Possible Orthologues:

Hck Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSNFUG00015013703
Gene Symbol: HCK
1 Cross references
202 Possible Orthologues:

Il2 Inducible T Cell Kinase

Ensembl ID : ENSNFUG00015013580
Gene Symbol: ITK
3 Cross references
205 Possible Orthologues:

Imp (Inosine 5'-Monophosphate) Dehydrogenase 1a

Ensembl ID : ENSNFUG00015018288
Gene Symbol: IMPDH1A
1 Cross references
258 Possible Orthologues:

Janus Kinase 1

Ensembl ID : ENSNFUG00015025398
Gene Symbol: JAK1
3 Cross references
212 Possible Orthologues:

Janus Kinase 2a

Ensembl ID : ENSNFUG00015025014
Gene Symbol: JAK2A
1 Cross references
199 Possible Orthologues:

Kit Proto-Oncogene, Receptor Tyrosine Kinase B

Ensembl ID : ENSNFUG00015017809
Gene Symbol: KITB
1 Cross references
200 Possible Orthologues:

Kras Proto-Oncogene, Gtpase

Ensembl ID : ENSNFUG00015024224
Gene Symbol: KRAS
3 Cross references
207 Possible Orthologues:

Malt1 Paracaspase

Ensembl ID : ENSNFUG00015024309
Gene Symbol: MALT1
3 Cross references
195 Possible Orthologues:

Map Kinase-Interacting Serine/threonine-Protein Kinase 2-Like

Ensembl ID : ENSNFUG00015016990
Gene Symbol: LOC107392870
3 Cross references
208 Possible Orthologues:

Mapk Activated Protein Kinase 2

Ensembl ID : ENSNFUG00015020201
Gene Symbol: MAPKAPK2
1 Cross references
187 Possible Orthologues:

Mapk Activated Protein Kinase 5

Ensembl ID : ENSNFUG00015011487
Gene Symbol: MAPKAPK5
3 Cross references
179 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).